Kazuma Maeno

601 total citations
32 papers, 444 citations indexed

About

Kazuma Maeno is a scholar working on Oncology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Kazuma Maeno has authored 32 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 11 papers in Surgery and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Kazuma Maeno's work include Thyroid Cancer Diagnosis and Treatment (8 papers), Cancer Treatment and Pharmacology (5 papers) and Thyroid and Parathyroid Surgery (5 papers). Kazuma Maeno is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (8 papers), Cancer Treatment and Pharmacology (5 papers) and Thyroid and Parathyroid Surgery (5 papers). Kazuma Maeno collaborates with scholars based in Japan, United Kingdom and Canada. Kazuma Maeno's co-authors include Ken‐ichi Ito, Tokiko Ito, Toshiharu Kanai, Toru Hanamura, Shin‐ichi Tsuchiya, Maiko Fujimori, Yoshihisa Hama, Morihiko Kimura, Kiyoshi Shingū and Muneaki Sano and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Clinical Cancer Research.

In The Last Decade

Kazuma Maeno

28 papers receiving 440 citations

Peers

Countries citing papers authored by Kazuma Maeno

Since Specialization

Citations

This map shows the geographic impact of Kazuma Maeno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuma Maeno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuma Maeno more than expected).

Fields of papers citing papers by Kazuma Maeno

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazuma Maeno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuma Maeno. The network helps show where Kazuma Maeno may publish in the future.

Co-authorship network of co-authors of Kazuma Maeno

This figure shows the co-authorship network connecting the top 25 collaborators of Kazuma Maeno. A scholar is included among the top collaborators of Kazuma Maeno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuma Maeno. Kazuma Maeno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Utility of contrast-enhanced magnetic resonance imaging for planning of surgical procedure in Paget’s disease of the breast 2025 ·Surgery Today ·Takaaki Oba, Kazuma Maeno, (unknown), (unknown), Yonghan Park, H. Morikawa, (unknown), Tadafumi Shimizu, (unknown), Tokiko Ito, Toshiharu Kanai, (unknown), Fumiyoshi Takayama, Ken‐ichi Ito	0
2	Significance of skeletal muscle index-to-body mass index ratio as a predictor of post-surgical bleeding after mastectomy in patients with breast cancer 2023 ·Breast Cancer ·H. Morikawa, Takaaki Oba, (unknown), (unknown), (unknown), (unknown), Tadafumi Shimizu, (unknown), Tokiko Ito, Toshiharu Kanai, Kazuma Maeno, Ken‐ichi Ito	2
3	Development of a predictive score for post-hemithyroidectomy hypothyroidism using skeletal muscle index, remnant thyroid index, and thyroid-stimulating hormone levels: a retrospective cohort study 2023 ·Quantitative Imaging in Medicine and Surgery ·(unknown), Takaaki Oba, (unknown), (unknown), H. Morikawa, (unknown), Tadafumi Shimizu, (unknown), Tokiko Ito, Toshiharu Kanai, Kazuma Maeno, (unknown)	0
4	Neutrophil-to-Lymphocyte Ratio Is Associated With the Proportion of Poorly Differentiated Components in Papillary Thyroid Carcinoma 2023 ·Journal of Surgical Research ·Takaaki Oba, Kazuma Maeno, (unknown), H. Morikawa, (unknown), (unknown), Tadafumi Shimizu, (unknown), Tokiko Ito, Toshiharu Kanai, Takeshi Uehara, Ken‐ichi Ito	1
5	Surgical resection of the primary tumor prevents an undesirable locoregional condition and improves the quality of life in patients with anaplastic thyroid cancer 2022 ·Surgery Today ·Toshiharu Kanai, Tokiko Ito, H. Morikawa, (unknown), Tadafumi Shimizu, Koichi Ohno, (unknown), (unknown), Kazuma Maeno, Ken‐ichi Ito	4
6	Changes in the pathophysiology of primary hyperparathyroidism and analysis of postoperative recurrence cases at a regional core hospital in Japan: experience of 35 years in Shinshu University Hospital 2022 ·Annals of Palliative Medicine ·Toshiharu Kanai, Takaaki Oba, H. Morikawa, (unknown), (unknown), Tadafumi Shimizu, (unknown), Kazuma Maeno, (unknown), Tokiko Ito	2
7	Skeletal muscle loss during neoadjuvant chemotherapy predicts poor prognosis in patients with breast cancer 2022 ·BMC Cancer ·(unknown), Takaaki Oba, (unknown), H. Morikawa, (unknown), (unknown), Tadafumi Shimizu, Koichi Ohno, (unknown), Tokiko Ito, Toshiharu Kanai, Kazuma Maeno, Ken‐ichi Ito	21
8	Prognostic Nutritional Index Is Superior to Neutrophil-to-lymphocyte Ratio as a Prognostic Marker in Metastatic Breast Cancer Patients Treated With Eribulin 2021 ·Anticancer Research ·Takaaki Oba, Kazuma Maeno, (unknown), Tokiko Ito, Toshiharu Kanai, Ken‐ichi Ito	16
9	Papillary thyroid microcarcinoma with lung metastases: a case report and review of the literature 2021 ·Thyroid Research ·Tadafumi Shimizu, Takaaki Oba, (unknown), (unknown), (unknown), Tokiko Ito, Toshiharu Kanai, Kazuma Maeno, Yoshinori Sato, Takeshi Uehara, Ken‐ichi Ito	9
10	Concomitant use of 18F-FDG PET-CT SUVmax is useful in the assessment of Ki67 labeling index in core-needle biopsy specimens of breast cancer 2021 ·Gland Surgery ·Hiroki Nakajima, Kazuma Maeno, Tokiko Ito, Toshiharu Kanai, (unknown), (unknown), Fumiyoshi Takayama, Tsuyoshi Uehara, Ken‐ichi Ito	3
11	Neoadjuvant chemotherapy-induced decrease of prognostic nutrition index predicts poor prognosis in patients with breast cancer 2020 ·BMC Cancer ·(unknown), Kazuma Maeno, (unknown), (unknown), Tokiko Ito, Toshiharu Kanai, Ken‐ichi Ito	31
12	Correlation of Clinicopathological Features and LGR5 Expression in Triple-Negative Breast Cancer 2020 ·Annals of Diagnostic Pathology ·(unknown), Takeshi Uehara, Tomoyuki Nakajima, Mai Iwaya, Kazuma Maeno, Shin‐ichi Tsuchiya, Hiroyoshi Ota, Ken‐ichi Ito	8
13	Lipid-rich carcinoma of the breast that is strongly positive for estrogen receptor: a case report and literature review 2016 ·OncoTargets and Therapy ·Ken‐ichi Ito, Takaaki Oba, (unknown), (unknown), Toru Hanamura, Takayuki Watanabe, Tokiko Ito, Toshiharu Kanai, Kazuma Maeno, Akihiko Yoshizawa, Fumiyoshi Takayama, Ayako Tateishi	6
14	[A retrospective study of high-dose toremifene treatment for patients with aromatase inhibitor refractory advanced or metastatic hormone receptor-positive breast cancer]. 2011 ·PubMed ·Hiroshi Koyama, (unknown), (unknown), Toshihiro Okada, Takayuki Watanabe, (unknown), Tokiko Ito, Kazuma Maeno, Yasuhiro Mochizuki, Ken‐ichi Ito, (unknown)	2
15	Multimodality therapeutic outcomes In anaplastic thyroid carcinoma: Improved survival in subgroups of patients with localized primary tumors 2011 ·Head & Neck ·Ken‐ichi Ito, Toru Hanamura, (unknown), Toshihiro Okada, Takayuki Watanabe, (unknown), Tokiko Ito, Hiroshi Koyama, Toshiharu Kanai, Kazuma Maeno, Yasuhiro Mochizuki, Jun Amano	87
16	Full-thickness chest-wall resection followed by thorax reconstruction for recurrent malignant phyllodes tumor 2010 ·International Journal of Clinical Oncology ·Tokiko Ito, Ken‐ichi Ito, Toshihiro Okada, (unknown), Toru Hanamura, Toshiharu Kanai, Kazuma Maeno, Yasuhiro Mochizuki, Ryoichi Kondo, Jun Amano, (unknown), Koji Asano	5
17	Molecular Basis for Reduced Estrone Sulfate Transport and Altered Modulator Sensitivity of Transmembrane Helix (TM) 6 and TM17 Mutants of Multidrug Resistance Protein 1 (ABCC1) 2009 ·Drug Metabolism and Disposition ·Kazuma Maeno, Akio Nakajima, Gwenaëlle Conseil, Alice J. Rothnie, Roger G. Deeley, Susan P.C. Cole	38
18	A CASE OF ANAPLASTIC THYROID CARCINOMA PERFORMED A TOTAL THYROIDECTOMY COMBINED WITH RESECTION OF THE INTRALUMINAL TUMOR THROMBUS IN THE INTERNAL JUGULAR VEIN 2007 ·Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) ·Ken‐ichi Ito, Tomoyuki Fujita, Kazuma Maeno, Yasuhiro Mochizuki, Maiko Fujimori, Jun Amano	0
19	Mutation of the class I β-tubulin gene does not predict response to paclitaxel for breast cancer 2003 ·Cancer Letters ·Kazuma Maeno, Ken‐ichi Ito, Yoshihisa Hama, Kiyoshi Shingū, Morihiko Kimura, Muneaki Sano, Hiroshi Nakagomi, Shin‐ichi Tsuchiya, Maiko Fujimori	34
20	DNA PLOIDY OF TESTICULAR GERM CELL TUMORS IN CHILDHOOD 1993 ·The Japanese Journal of Urology ·Akiko Kashiwagi, Satoshi Nagamori, (unknown), Kazuma Maeno, Takashi Koyanagi	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact